New Methods and Models for the Isoniazid Acetylation Polymorphism
暂无分享,去创建一个
[1] W. Weber,et al. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. , 1978, Molecular pharmacology.
[2] J. Oates,et al. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. , 1978, The New England journal of medicine.
[3] J. Davidson,et al. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. , 1978, The American journal of psychiatry.
[4] C. Mcqueen,et al. N-Acetylation of drugs. A genetically controlled reciprocal relationship between drug N-acetylating enzymes of rabbit liver and peripheral blood cells. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[5] R. Larsson,et al. Spontaneous systemic lupus erythematosus and acelylator phenotype. , 2009, Acta medica Scandinavica.
[6] P. K. Lunde,et al. Disease and Acetylation Polymorphism , 1977, Clinical pharmacokinetics.
[7] E. Hess,et al. Acetylator phenotype in systemic lupus erythematosus. , 1977, Arthritis and rheumatism.
[8] E. Johnstone. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine , 1976, Psychopharmacologia.
[9] S. Thorgeirsson,et al. Genetic differences in 2-acetylaminofluorene mutagenicity in vitro associated with mouse hepatic aryl hydrocarbon hydroxylase activity induced by polycyclic aromatic compounds. , 1976, Molecular pharmacology.
[10] U. Thorgeirsson,et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. , 1976, Annals of internal medicine.
[11] J. H. Martin,et al. The acetylator phenotype of patients with systemic lupus erythematosus. , 1974, Drug metabolism and disposition: the biological fate of chemicals.
[12] G. Bryan,et al. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. , 1973, Biochemical pharmacology.
[13] W. Weber. ACETYLATION OF DRUGS , 1973 .
[14] I. Mackay,et al. Antinuclear antibody response to procainamide in man and laboratory animals. , 1972, American heart journal.
[15] T. Feltkamp,et al. Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA). , 1972, Clinical and experimental immunology.
[16] E. Dubois,et al. Failure of procainamide to induce a systemic lupus erythematosus-like disease in animals. , 1972, Toxicology and applied pharmacology.